tiprankstipranks
Trending News
More News >

New Portfolio - New Portfolio

Joe Barnes

New Portfolio
Individual Investor
Ranked #347,332 out of 830,087 TipRanks' Investors
Success Rate
36%
56 out of 155
profitable transactions
Average Return
38.48%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 5.17%
6-Month Return▲ 41.67%
12-Month Return▲ 25.03%
YTD Return▲ 32.52%
Total Return▲ 14.24%

Best Trade

Opened at
Closed at-
Gain▲ 666.18%

Bio

My investment portfolio

Performance

14.73%0-14.73%
▲ 0.80%
▼ 0.87%
▼ 4.51%
Apr 2025
▲ 11.63%
▲ 6.28%
▼ 2.73%
May 2025
▲ 9.25%
▲ 5.14%
▲ 14.73%
Jun 2025
▲ 7.60%
▲ 2.30%
▲ 8.53%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 8.05%
Aug 2025
▲ 12.88%
▲ 3.56%
▼ 0.33%
Sep 2025
▲ 10.96%
▲ 2.38%
▲ 4.82%
Oct 2025
▼ 4.25%
▼ 0.35%
▲ 2.90%
Nov 2025
TipRanks AverageS&P 500Investor Portfolio
▲ 0.80%▼ 0.87%▼ 4.51%
▲ 11.63%▲ 6.28%▼ 2.73%
▲ 9.25%▲ 5.14%▲ 14.73%
▲ 7.60%▲ 2.30%▲ 8.53%
▲ 2.76%▲ 2.05%▲ 8.05%
▲ 12.88%▲ 3.56%▼ 0.33%
▲ 10.96%▲ 2.38%▲ 4.82%
▼ 4.25%▼ 0.35%▲ 2.90%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Nuvation Bio
0%
▲ 58.93%
1
Open
Oct 25, 2025
Intel
0%
▲ 25.46%
1
Open
Sep 23, 2025
Palantir Technologies
0%
▼ 9.19%
1
Open
Sep 23, 2025
Quantum Computing
0%
▼ 46.46%
1
Open
Sep 23, 2025
AT&T
0%
▲ 2.10%
1
Open
Mar 13, 2025
T Mobile US
0%
▼ 19.24%
1
Open
Mar 13, 2025
Marinus
▼ 94.54%
4
Close
Feb 10, 2025
Bellerophon
▼ 99.82%
4
Close
Dec 18, 2024
Applied Digital Corporation
0%
▲ 172.27%
1
Open
Nov 19, 2024
Pulmatrix
0%
▼ 25.64%
3
Open
Nov 17, 2024
BYD Company
0%
▲ 8.61%
1
Open
Nov 12, 2024
Devon Energy
9.65%
▼ 34.14%
16
Buy
Apr 06, 2024
Ardelyx
40.55%
▲ 57.50%
9
Buy
Jan 25, 2024
Oncolytics Biotech
0%
▼ 45.55%
1
Open
Jun 18, 2023
Immuneering
0%
▼ 34.24%
1
Open
Jun 18, 2023
Adverum Biotechnologies
0%
▼ 72.63%
1
Open
Jun 18, 2023
Carisma Therapeutics
0%
▼ 55.01%
3
Open
May 04, 2023
Nvidia
0%
▲ 258.59%
3
Open
Apr 03, 2023
Assertio Therapeutics
3.33%
▼ 85.49%
6
Sell
Mar 13, 2023
GlobalFoundries Inc
0.54%
▼ 38.92%
10
Sell
Mar 09, 2023